biomaterials

BIOINTERPHASE is a mission-driven bioengineering studio whose mission is to Restore and Reinforce Biological Needs with Sustainable Biointerfaces. Its core competencies are in Biomaterials & Biosignals Intelligence. The company's vision is to be a long-lasting bioengineering company where science, engineering, art, and passion meet to create impactful products for good.

bioengineeringbiosignals intelligence

Diopter Technologies develops bio-integrated contact lens technologies for treating eye diseases, combining drug delivery systems with advanced lens designs as a non-surgical alternative. Founded in 2018, the company holds multiple patents covering biomimetic drug-eluting platforms and is developing a dissolving amniotic membrane and biopolymer contact lens for ocular surface diseases.

clinical studiescontact lens designdrug delivery systems

ImmunoShield Therapeutics is a biotechnology company developing an enabling platform for allogeneic cell therapy designed to protect therapeutic cells and support long-term function after implantation, with a focus on treating Type 1 Diabetes. The company builds a technology layer that complements and strengthens therapeutic programs, aiming to improve protection, persistence, and practicality of implanted insulin-secreting cells without broad immune suppression.

cell therapycell transplantationimmune engineering